Altimmune Inc (NAS:ALT)
$ 8.57 -0.16 (-1.83%) Market Cap: 609.54 Mil Enterprise Value: 471.93 Mil PE Ratio: 0 PB Ratio: 4.57 GF Score: 30/100

Q4 2021 Altimmune Inc Earnings Call Transcript

Mar 15, 2022 / 12:30PM GMT
Release Date Price: $5.9 (-8.24%)
Operator

Good day, ladies and gentlemen, and welcome to the Altimmune Inc. Full Year and Q4 Earnings Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

I would now like to introduce your host for today's conference, Rich Eisenstadt, Chief Financial Officer at Altimmune. Rich, you may begin.

Richard I. Eisenstadt
Altimmune, Inc. - CFO and Principal Financial & Accounting Officer

Thank you, Jonathan, and good morning, everyone. Thank you for participating in Altimmune's Full Year and Fourth Quarter 2021 Earnings Conference Call. Members of the Altimmune team joining me on the call today are Vipin Garg, our Chief Executive Officer; Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer.

Following the prepared remarks, we will hold a question-and-answer session. A press release with our full year and fourth quarter 2021 financial results was issued this morning and can be found on the Investor Relations section of the company's website.

Before we begin, I would like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot